Zobrazeno 1 - 10
of 508
pro vyhledávání: '"Graham R. Foster"'
Autor:
Ambreen Arif, Aliya Hasnain, Auj Chaudhry, Muhammad Asim, Muhammad Nabeel Shafqat, Abeer Altaf, Noor Saba, Polychronis Kemos, M. Azim Ansari, Eleanor Barnes, Chris Metcalfe, Peter Vickerman, Huma Qureshi, Saeed Hamid, Asad Ali Choudhry, Saad Khalid Niaz, Graham R. Foster, Naheed Choudhry
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background Pakistan has one of the highest burdens of Hepatitis C virus (HCV) infection globally. To achieve the World Health Organization’s goals for HCV elimination, there is a need for substantial scale-up in testing, treatment, and a r
Externí odkaz:
https://doaj.org/article/820c17ee86244acca090e92b3083a7a5
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-13 (2022)
Abstract Background People with liver disease are at increased risk of developing cardiovascular disease (CVD), however, there has yet been an investigation of incidence burden, risk, and premature mortality across a wide range of liver conditions an
Externí odkaz:
https://doaj.org/article/7124147f6c554143a86f246dcbce5ec5
Autor:
Alvina G. Lai, Wai Hoong Chang, Constantinos A. Parisinos, Michail Katsoulis, Ruth M. Blackburn, Anoop D. Shah, Vincent Nguyen, Spiros Denaxas, George Davey Smith, Tom R. Gaunt, Krishnarajah Nirantharakumar, Murray P. Cox, Donall Forde, Folkert W. Asselbergs, Steve Harris, Sylvia Richardson, Reecha Sofat, Richard J. B. Dobson, Aroon Hingorani, Riyaz Patel, Jonathan Sterne, Amitava Banerjee, Alastair K. Denniston, Simon Ball, Neil J. Sebire, Nigam H. Shah, Graham R. Foster, Bryan Williams, Harry Hemingway
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background An Informatics Consult has been proposed in which clinicians request novel evidence from large scale health data resources, tailored to the treatment of a specific patient. However, the availability of such consultations is lackin
Externí odkaz:
https://doaj.org/article/78307b29f564469e8cd433172aa802e4
Autor:
David A. Smith, Carlota Fernandez-Antunez, Andrea Magri, Rory Bowden, Nimisha Chaturvedi, Jacques Fellay, John McLauchlan, Graham R. Foster, William L. Irving, STOP-HCV Consortium, Peter Simmonds, Vincent Pedergnana, Santseharay Ramirez, Jens Bukh, Eleanor Barnes, M. Azim Ansari
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-11 (2021)
Sofosbuvir is a common therapy in hepatitis C virus infection, which targets the NS5B polymerase. Here, Smith et al. analyze the association between whole genome HCV polymorphisms and sofosbuvir treatment failure and identify three common polymorphis
Externí odkaz:
https://doaj.org/article/fba960aa3b6a4946a4842f08d7a24e6d
Publikováno v:
BJPsych Open, Vol 8 (2022)
The burden of mental illness in young people with chronic liver disease is not known. In this population cohort study in England, we identified 358 individuals (aged ≤25 years) diagnosed with autoimmune hepatitis or liver disease related to cystic
Externí odkaz:
https://doaj.org/article/9ad11ac4decb412ab2160274e42d445c
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 11, Iss 4, Pp 1163-1175 (2021)
Background & Aims: Despite recent advances in antiviral therapy for hepatitis C virus (HCV), a proportion of patients with genotype 3 (G3) HCV infection do not respond to current all oral treatment regimens. Genomic analyses have identified key polym
Externí odkaz:
https://doaj.org/article/6c39e48d9bbc464cbed1a05c1ca37738
Autor:
Naheed Choudhry, Kate Drysdale, Carla Usai, Dean Leighton, Vinay Sonagara, Ruaridh Buchanan, Manreet Nijjar, Sherine Thomas, Mark Hopkins, Teresa Cutino-Moguel, Upkar S. Gill, Graham R. Foster, Patrick T. Kennedy
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Introduction: SARS-CoV-2 antibody detection serves as an important diagnostic marker for past SARS-CoV-2 infection and is essential to determine the spread of COVID-19, monitor potential COVID-19 long-term effects, and to evaluate possible protection
Externí odkaz:
https://doaj.org/article/e618f7953744421d88fbbeb8b3fe4c1a
Autor:
Helen R. Stagg, Julian Surey, Marie Francis, Jennifer MacLellan, Graham R. Foster, André Charlett, Ibrahim Abubakar
Publikováno v:
BMC Medicine, Vol 17, Iss 1, Pp 1-9 (2019)
Abstract Background Peer support can enable patient engagement with healthcare services, particularly for marginalised populations. In this randomised controlled trial, the efficacy of a peer support intervention at promoting successful engagement wi
Externí odkaz:
https://doaj.org/article/2c90f140e792488a9b117dae056d05a4
Autor:
Edford Sinkala, Michael Vinikoor, Alice Miyanda Siyunda, Kanekwa Zyambo, Ellen Besa, Bright Nsokolo, Gilles Wandeler, Graham R. Foster, Paul Kelly
Publikováno v:
Heliyon, Vol 6, Iss 7, Pp e04534- (2020)
Cirrhosis commonly complicates portal hypertension worldwide but in Zambia hepatosplenic schistosomiasis (HSS) dominates as the cause of portal hypertension. We need easier and non-invasive ways to assess HSS. Transient elastography (TE), a measure o
Externí odkaz:
https://doaj.org/article/a67de41b112443c2a9865180e6797e38
Autor:
Donald M. Jensen, Tarik Asselah, Douglas Dieterich, Graham R. Foster, Mark S. Sulkowski, Stefan Zeuzem, Parvez Mantry, Eric M. Yoshida, Christophe Moreno, Denis Ouzan, Mark Wright, Luis E. Morano, Robert Buynak, Marc Bourlière, Tarek Hassanein, Shuhei Nishiguchi, Jia-Horng Kao, Masao Omata, Seung W. Paik, David K. Wong, Edward Tam, Kelly Kaita, S. Victor Feinman, Jerry O. Stern, Joseph Scherer, Anne-Marie Quinson, Florian Voss, John-Paul Gallivan, Wulf O. Böcher, Peter Ferenci
Publikováno v:
Annals of Hepatology, Vol 15, Iss 3, Pp 333-349 (2016)
Introduction & aim. Faldaprevir is a potent once-daily (q.d.) hepatitis C virus (HCV) NS3/4A protease inhibitor. The STARTVerso1 and STARTVerso2 phase 3 studies evaluated faldaprevir plus peginterferon alfa-2a/ribavirin (PegIFN/RBV) in treatment-naï
Externí odkaz:
https://doaj.org/article/dda945401c9c4406bf45486119425e6e